Science Explorer Back to mapMap
Discussion
Researcher · Rigshospitalet · Denmark

Carsten Utoft Niemann

Carsten Utoft Niemann publishes mostly in Genetics, Pathology and Forensic Medicine and Immunology, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Immunodeficiency and Autoimmune Disorders.

ORCID 0000-0001-9880-5242 OpenAlex
World rank
#252,803
of 7,710,434 ranked researchers
Rank in Denmark
#1,738
of 43,819
Works
455
Citations
10k
Citations per work
22.2
h-index
49
i10-index 126Top 4.4% in Genetics (Medicine)
Carsten Utoft Niemann

What does Carsten Utoft Niemann research?

Carsten Utoft Niemann's work is mostly in Medicine (61%), Immunology and Microbiology (12%).

Health Sciences: 276 works · 60.6% of their workMedicine: 276 works · 60.6% of their workGenetics: 122 works · 26.8% of their workPathology and Forensic Medicine: 77 works · 16.9% of their workOncology: 36 works · 7.9% of their workHematology: 21 works · 4.6% of their workPulmonary and Respiratory Medicine: 20 works · 4.4% of their workEverything else: 124 works · 27.2% of their workLife Sciences: 56 works · 12.2% of their workImmunology and Microbiology: 56 works · 12.2% of their workImmunology: 56 works · 12.2% of their workTHEIR WORKCarsten UtoftNiemann455works
Life Sciences12%Health Sciences61%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine27660.6%
  2. Everything else12427.2%
    1. Immunology and Microbiology5612.2%
  1. 1Genetics27% of their works
  2. 2Pathology and Forensic Medicine17% of their works
  3. 3Immunology12% of their works
  4. 4Oncology8% of their works
  5. 5Hematology5% of their works
  6. 6Pulmonary and Respiratory Medicine4% of their works

Research topics

Which keywords describe Carsten Utoft Niemann's research?

The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Lymphoma, Classification, Molecular Profiling, Genetic Mutations and Primary Immunodeficiency.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Rituximab4332 topics
  2. Chronic Lymphocytic Leukemia2681 topic
  3. Genomic Aberrations2681 topic
  4. Lymphoma1802 topics
  5. Classification1651 topic
  6. Molecular Profiling1651 topic
  7. Genetic Mutations731 topic
  8. Primary Immunodeficiency731 topic
  9. Cancer Immunotherapy432 topics
  10. Breast Cancer311 topic
  11. CDK4/6 Inhibitors311 topic
  12. CD47281 topic
  13. apoptotic cells281 topic
  14. BCR-ABL221 topic
  15. Imatinib221 topic
  16. CAR T Cells151 topic
  17. Chimeric Antigen Receptor151 topic
  18. Diagnosis Criteria151 topic
  19. International Myeloma Working Group151 topic

Where does Carsten Utoft Niemann work?

Carsten Utoft Niemann's main affiliation in the publication record is Rigshospitalet, Denmark.

How many publications and citations does Carsten Utoft Niemann have?

OpenAlex counts 455 works and 10,114 citations for Carsten Utoft Niemann, an h-index of 49, ranking #252,803 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Carsten Utoft Niemann. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.